JP2023525756A5 - - Google Patents
Info
- Publication number
- JP2023525756A5 JP2023525756A5 JP2022567881A JP2022567881A JP2023525756A5 JP 2023525756 A5 JP2023525756 A5 JP 2023525756A5 JP 2022567881 A JP2022567881 A JP 2022567881A JP 2022567881 A JP2022567881 A JP 2022567881A JP 2023525756 A5 JP2023525756 A5 JP 2023525756A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- independently
- alkyl
- case
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025169839A JP2026027231A (ja) | 2020-05-08 | 2025-10-08 | Akt3モジュレーター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021987P | 2020-05-08 | 2020-05-08 | |
| US63/021,987 | 2020-05-08 | ||
| US202063121001P | 2020-12-03 | 2020-12-03 | |
| US63/121,001 | 2020-12-03 | ||
| PCT/US2021/031325 WO2021226477A1 (en) | 2020-05-08 | 2021-05-07 | Akt3 modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169839A Division JP2026027231A (ja) | 2020-05-08 | 2025-10-08 | Akt3モジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023525756A JP2023525756A (ja) | 2023-06-19 |
| JP2023525756A5 true JP2023525756A5 (cg-RX-API-DMAC10.html) | 2024-05-16 |
| JP7757312B2 JP7757312B2 (ja) | 2025-10-21 |
Family
ID=78468493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567881A Active JP7757312B2 (ja) | 2020-05-08 | 2021-05-07 | Akt3モジュレーター |
| JP2025169839A Pending JP2026027231A (ja) | 2020-05-08 | 2025-10-08 | Akt3モジュレーター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169839A Pending JP2026027231A (ja) | 2020-05-08 | 2025-10-08 | Akt3モジュレーター |
Country Status (12)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158266C (zh) * | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
| TW200536536A (en) | 2004-02-25 | 2005-11-16 | Schering Corp | Pyrazolotriazines as kinase inhibitors |
| US7939546B2 (en) * | 2007-10-12 | 2011-05-10 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| KR101106050B1 (ko) * | 2009-03-25 | 2012-01-18 | 한국과학기술연구원 | 아미노퀴놀린 화합물, 이의 제조 방법 및 이를 함유하는 의약 조성물 |
| RU2016122731A (ru) * | 2013-11-25 | 2018-01-09 | Новоген Лтд | Функционализированные и замещенные индолы в качестве противораковых агентов |
| CN106543143B (zh) * | 2015-09-22 | 2019-03-22 | 合肥中科普瑞昇生物医药科技有限公司 | 一类新型的flt3激酶抑制剂及其用途 |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| US10342868B2 (en) * | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| US11291719B2 (en) | 2016-01-15 | 2022-04-05 | Augusta University Research Institute, Inc. | Methods and compositions for modulating Akt3 |
| CN106496107A (zh) * | 2016-08-31 | 2017-03-15 | 浙江永宁药业股份有限公司 | Vegfr‑2抑制剂及其制备方法 |
| WO2021212111A1 (en) | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
| US20230295114A1 (en) | 2020-05-08 | 2023-09-21 | Georgiamune Llc | Akt3 modulators |
-
2021
- 2021-05-07 WO PCT/US2021/031325 patent/WO2021226477A1/en not_active Ceased
- 2021-05-07 PH PH1/2022/553034A patent/PH12022553034A1/en unknown
- 2021-05-07 IL IL297597A patent/IL297597A/en unknown
- 2021-05-07 JP JP2022567881A patent/JP7757312B2/ja active Active
- 2021-05-07 MX MX2022014018A patent/MX2022014018A/es unknown
- 2021-05-07 EP EP21800442.2A patent/EP4146185A4/en active Pending
- 2021-05-07 BR BR112022022549A patent/BR112022022549A2/pt unknown
- 2021-05-07 KR KR1020227042312A patent/KR20230022458A/ko active Pending
- 2021-05-07 CN CN202180046152.3A patent/CN115867266A/zh active Pending
- 2021-05-07 CA CA3182273A patent/CA3182273A1/en active Pending
- 2021-05-07 US US17/923,811 patent/US20240228457A1/en active Pending
- 2021-05-07 AU AU2021267042A patent/AU2021267042A1/en active Pending
-
2025
- 2025-10-08 JP JP2025169839A patent/JP2026027231A/ja active Pending
- 2025-10-22 IL IL324152A patent/IL324152A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023525757A5 (cg-RX-API-DMAC10.html) | ||
| AU2023202592B2 (en) | Modulators of the integrated stress pathway | |
| JP2023524600A5 (cg-RX-API-DMAC10.html) | ||
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| JP2023524596A5 (cg-RX-API-DMAC10.html) | ||
| JP7307057B2 (ja) | 統合的ストレス経路の調節剤 | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| AU2018360850A1 (en) | Modulators of the integrated stress pathway | |
| CA2643177A1 (en) | Multi-cyclic compounds for treating cancer | |
| JP2024541995A5 (cg-RX-API-DMAC10.html) | ||
| HUP0301213A2 (hu) | Ciklin dependens kinázok amino-tiazol inhibitorai, ezeket tartalmazó gyógyszerkészítmények, előállításuk és alkalmazásuk | |
| CZ297907B6 (cs) | Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem | |
| CA3008747A1 (en) | Novel compounds | |
| EP3704089A1 (en) | Modulators of the integrated stress pathway | |
| MX2009001036A (es) | Pirazolopirimidinas, proceso para su preparacion y su uso como medicina. | |
| JP2010528021A5 (cg-RX-API-DMAC10.html) | ||
| JP2024540107A5 (cg-RX-API-DMAC10.html) | ||
| JP2017532360A5 (cg-RX-API-DMAC10.html) | ||
| JP2021535112A5 (cg-RX-API-DMAC10.html) | ||
| KR20090055562A (ko) | 오로라 a 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체 | |
| JP2022536901A5 (cg-RX-API-DMAC10.html) | ||
| TWI544920B (zh) | N-羥基-4-{2-[3-(n,n-二甲基胺基甲基)苯並呋喃-2-基羰基胺基]乙氧基}苯甲醯胺之新穎投藥法 | |
| JP2009504771A5 (cg-RX-API-DMAC10.html) | ||
| JP2024541994A5 (cg-RX-API-DMAC10.html) | ||
| CN106414448B (zh) | 可用作s100-抑制剂的新型化合物 |